| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 253.5 | 96.0 | 491.0 | 100.0 | 250.5 | 542.5 | 32.0 | 1.0 | - | - | 1766.5 |
| 1 | 8.0 | - | 0.5 | - | 19.5 | 162.5 | 18.5 | 0.5 | - | - | 209.5 |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | - | - |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 118.5 |
| 1 | 118.0 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | 65.0 |
| 1 | 370.5 |
| Number of post synapses: | 3533 |
| Number of pre synapses: | 419 |
| Number of output connections: | 1000 |
| Coverage factor: | 1.2 |
| Columnar completeness: | 0.67 |
| Area completeness: | 0.94 |
| Cell size (columns): | 372 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| instance | NT | total connections | connections /#aMe12 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Dm9 (R) | Glu | 1,018 | 509.0 | 28.0% | 28.0% |
| 1 | R8p (R) | His | 373 | 186.5 | 10.3% | 38.2% |
| 2 | MeVPMe13 (L) | ACh | 184 | 92.0 | 5.1% | 43.3% |
| 3 | R7p (R) | His | 165 | 82.5 | 4.5% | 47.8% |
| 4 | Dm8b (R) | Glu | 161 | 80.5 | 4.4% | 52.2% |
| 5 | Dm2 (R) | ACh | 117 | 58.5 | 3.2% | 55.5% |
| 6 | aMe4 (R) | ACh | 116 | 58.0 | 3.2% | 58.6% |
| 7 | R7_unclear (R) | His | 116 | 58.0 | 3.2% | 61.8% |
| 8 | Mi10 (R) | ACh | 113 | 56.5 | 3.1% | 64.9% |
| 9 | R8_unclear (R) | His | 78 | 39.0 | 2.1% | 67.1% |
| 10 | Dm8a (R) | Glu | 76 | 38.0 | 2.1% | 69.2% |
| 11 | Mi15 (R) | ACh | 76 | 38.0 | 2.1% | 71.3% |
| 12 | MeVPMe12 (L) | ACh | 74 | 37.0 | 2.0% | 73.3% |
| 13 | Cm11d (R) | ACh | 65 | 32.5 | 1.8% | 75.1% |
| 14 | Cm9 (R) | Glu | 55 | 27.5 | 1.5% | 76.6% |
| 15 | Dm11 (R) | Glu | 47 | 23.5 | 1.3% | 77.9% |
| 16 | aMe17b (R) | GABA | 43 | 21.5 | 1.2% | 79.1% |
| 17 | Cm11b (R) | ACh | 42 | 21.0 | 1.2% | 80.2% |
| 18 | MeVPMe12 (R) | ACh | 41 | 20.5 | 1.1% | 81.3% |
| 19 | MeVPMe13 (R) | ACh | 38 | 19.0 | 1.0% | 82.4% |
| 20 | aMe22 (R) | Glu | 36 | 18.0 | 1.0% | 83.4% |
| 21 | MeVPLo2 (R) | ACh | 33 | 16.5 | 0.9% | 84.3% |
| 22 | Tm5c (R) | Glu | 31 | 15.5 | 0.9% | 85.1% |
| 23 | aMe30 (R) | Glu | 30 | 15.0 | 0.8% | 86.0% |
| 24 | aMe2 (R) | Glu | 29 | 14.5 | 0.8% | 86.8% |
| 25 | OA-AL2i3 (R) | OA | 29 | 14.5 | 0.8% | 87.6% |
| 26 | aMe12 (R) | ACh | 15 | 7.5 | 0.4% | 88.0% |
| 27 | aMe23 (R) | unclear | 15 | 7.5 | 0.4% | 88.4% |
| 28 | aMe5 (R) | ACh | 15 | 7.5 | 0.4% | 88.8% |
| 29 | MeVC11 (L) | ACh | 15 | 7.5 | 0.4% | 89.2% |
| 30 | aMe17a (R) | Glu | 13 | 6.5 | 0.4% | 89.6% |
| 31 | MeVP9 (R) | ACh | 13 | 6.5 | 0.4% | 89.9% |
| 32 | MeVPMe7 (L) | Glu | 12 | 6.0 | 0.3% | 90.2% |
| 33 | MeLo1 (R) | ACh | 11 | 5.5 | 0.3% | 90.5% |
| 34 | OA-AL2i4 (R) | OA | 11 | 5.5 | 0.3% | 90.8% |
| 35 | Cm31a (R) | GABA | 10 | 5.0 | 0.3% | 91.1% |
| 36 | MeTu1 (R) | ACh | 10 | 5.0 | 0.3% | 91.4% |
| 37 | MeVP8 (R) | ACh | 10 | 5.0 | 0.3% | 91.7% |
| 38 | MeVPLo2 (L) | ACh | 10 | 5.0 | 0.3% | 91.9% |
| 39 | Cm28 (R) | unclear | 9 | 4.5 | 0.2% | 92.2% |
| 40 | Dm-DRA2 (R) | Glu | 8 | 4.0 | 0.2% | 92.4% |
| 41 | MeVC20 (R) | Glu | 8 | 4.0 | 0.2% | 92.6% |
| 42 | MeVC22 (R) | Glu | 8 | 4.0 | 0.2% | 92.9% |
| 43 | R7y (R) | His | 8 | 4.0 | 0.2% | 93.1% |
| 44 | Cm1 (R) | ACh | 7 | 3.5 | 0.2% | 93.3% |
| 45 | Cm2 (R) | ACh | 7 | 3.5 | 0.2% | 93.5% |
| 46 | Cm7 (R) | Glu | 7 | 3.5 | 0.2% | 93.7% |
| 47 | Cm27 (R) | Glu | 6 | 3.0 | 0.2% | 93.8% |
| 48 | Dm-DRA1 (R) | Glu | 6 | 3.0 | 0.2% | 94.0% |
| 49 | R7d (R) | His | 6 | 3.0 | 0.2% | 94.1% |
| 50 | R8y (R) | His | 6 | 3.0 | 0.2% | 94.3% |
| 51 | Tm5b (R) | ACh | 6 | 3.0 | 0.2% | 94.5% |
| 52 | aMe1 (R) | GABA | 5 | 2.5 | 0.1% | 94.6% |
| 53 | aMe6c (R) | Glu | 5 | 2.5 | 0.1% | 94.8% |
| 54 | Cm11a (R) | ACh | 5 | 2.5 | 0.1% | 94.9% |
| 55 | Cm11c (R) | ACh | 5 | 2.5 | 0.1% | 95.0% |
| 56 | Cm4 (R) | Glu | 5 | 2.5 | 0.1% | 95.2% |
| 57 | MeTu3c (R) | ACh | 5 | 2.5 | 0.1% | 95.3% |
| 58 | Mi1 (R) | ACh | 5 | 2.5 | 0.1% | 95.4% |
| 59 | Tm30 (R) | GABA | 5 | 2.5 | 0.1% | 95.6% |
| 60 | aMe17e (R) | Glu | 4 | 2.0 | 0.1% | 95.7% |
| 61 | Cm3 (R) | GABA | 4 | 2.0 | 0.1% | 95.8% |
| 62 | Cm8 (R) | GABA | 4 | 2.0 | 0.1% | 95.9% |
| 63 | Dm20 (R) | Glu | 4 | 2.0 | 0.1% | 96.0% |
| 64 | MeVPaMe2 (L) | Glu | 4 | 2.0 | 0.1% | 96.1% |
| 65 | OA-AL2i1 (R) | OA | 4 | 2.0 | 0.1% | 96.2% |
| 66 | Tm26 (R) | ACh | 4 | 2.0 | 0.1% | 96.3% |
| 67 | 5thsLNv_LNd6 (R) | ACh | 3 | 1.5 | 0.1% | 96.4% |
| 68 | Cm20 (R) | GABA | 3 | 1.5 | 0.1% | 96.5% |
| 69 | Cm26 (R) | Glu | 3 | 1.5 | 0.1% | 96.6% |
| 70 | Cm30 (R) | GABA | 3 | 1.5 | 0.1% | 96.7% |
| 71 | Cm31b (R) | GABA | 3 | 1.5 | 0.1% | 96.8% |
| 72 | Cm33 (R) | GABA | 3 | 1.5 | 0.1% | 96.8% |
| 73 | Cm35 (R) | GABA | 3 | 1.5 | 0.1% | 96.9% |
| 74 | Dm12 (R) | Glu | 3 | 1.5 | 0.1% | 97.0% |
| 75 | HBeyelet (R) | His | 3 | 1.5 | 0.1% | 97.1% |
| 76 | MeVP14 (R) | ACh | 3 | 1.5 | 0.1% | 97.2% |
| 77 | MeVP7 (R) | ACh | 3 | 1.5 | 0.1% | 97.3% |
| 78 | R7R8_unclear (R) | unclear | 3 | 1.5 | 0.1% | 97.3% |
| 79 | Tm20 (R) | ACh | 3 | 1.5 | 0.1% | 97.4% |
| 80 | Tm39 (R) | ACh | 3 | 1.5 | 0.1% | 97.5% |
| 81 | TmY5a (R) | Glu | 3 | 1.5 | 0.1% | 97.6% |
| 82 | aMe12 (L) | ACh | 2 | 1.0 | 0.1% | 97.6% |
| 83 | aMe17c (R) | Glu | 2 | 1.0 | 0.1% | 97.7% |
| 84 | aMe6b (R) | ACh | 2 | 1.0 | 0.1% | 97.7% |
| 85 | aMe9 (L) | ACh | 2 | 1.0 | 0.1% | 97.8% |
| 86 | Cm10 (R) | GABA | 2 | 1.0 | 0.1% | 97.9% |
| 87 | Cm12 (R) | GABA | 2 | 1.0 | 0.1% | 97.9% |
| 88 | Cm21 (R) | GABA | 2 | 1.0 | 0.1% | 98.0% |
| 89 | Cm5 (R) | GABA | 2 | 1.0 | 0.1% | 98.0% |
| 90 | Dm10 (R) | GABA | 2 | 1.0 | 0.1% | 98.1% |
| 91 | Dm4 (R) | Glu | 2 | 1.0 | 0.1% | 98.1% |
| 92 | DNc01 (L) | unclear | 2 | 1.0 | 0.1% | 98.2% |
| 93 | l-LNv (L) | unclear | 2 | 1.0 | 0.1% | 98.2% |
| 94 | L2 (R) | ACh | 2 | 1.0 | 0.1% | 98.3% |
| 95 | L5 (R) | ACh | 2 | 1.0 | 0.1% | 98.4% |
| 96 | Lat3 (R) | unclear | 2 | 1.0 | 0.1% | 98.4% |
| 97 | LT58 (R) | Glu | 2 | 1.0 | 0.1% | 98.5% |
| 98 | MeTu3b (R) | ACh | 2 | 1.0 | 0.1% | 98.5% |
| 99 | MeVC27 (L) | unclear | 2 | 1.0 | 0.1% | 98.6% |
| 100 | MeVP1 (R) | ACh | 2 | 1.0 | 0.1% | 98.6% |
| 101 | MeVP2 (R) | ACh | 2 | 1.0 | 0.1% | 98.7% |
| 102 | MeVP20 (R) | unclear | 2 | 1.0 | 0.1% | 98.7% |
| 103 | MeVP31 (R) | ACh | 2 | 1.0 | 0.1% | 98.8% |
| 104 | MeVP43 (R) | ACh | 2 | 1.0 | 0.1% | 98.8% |
| 105 | MeVPMe11 (R) | Glu | 2 | 1.0 | 0.1% | 98.9% |
| 106 | Tm29 (R) | Glu | 2 | 1.0 | 0.1% | 99.0% |
| 107 | Tm37 (R) | Glu | 2 | 1.0 | 0.1% | 99.0% |
| 108 | Tm5a (R) | ACh | 2 | 1.0 | 0.1% | 99.1% |
| instance | NT | total connections | connections /#aMe12 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | 5thsLNv_LNd6 (R) | ACh | 162 | 81.0 | 6.7% | 6.7% |
| 1 | aMe30 (R) | Glu | 131 | 65.5 | 5.4% | 12.1% |
| 2 | Tm37 (R) | Glu | 130 | 65.0 | 5.4% | 17.4% |
| 3 | aMe4 (R) | ACh | 118 | 59.0 | 4.9% | 22.3% |
| 4 | MeVPMe12 (R) | ACh | 117 | 58.5 | 4.8% | 27.1% |
| 5 | LoVC23 (L) | GABA | 110 | 55.0 | 4.5% | 31.6% |
| 6 | Tm30 (R) | GABA | 110 | 55.0 | 4.5% | 36.1% |
| 7 | aMe6c (R) | Glu | 108 | 54.0 | 4.4% | 40.6% |
| 8 | OA-AL2i3 (R) | OA | 91 | 45.5 | 3.7% | 44.3% |
| 9 | aMe22 (R) | Glu | 79 | 39.5 | 3.3% | 47.6% |
| 10 | Cm31a (R) | GABA | 62 | 31.0 | 2.6% | 50.1% |
| 11 | Lat3 (R) | unclear | 58 | 29.0 | 2.4% | 52.5% |
| 12 | Cm6 (R) | GABA | 49 | 24.5 | 2.0% | 54.5% |
| 13 | MeVP7 (R) | ACh | 48 | 24.0 | 2.0% | 56.5% |
| 14 | aMe24 (R) | unclear | 40 | 20.0 | 1.6% | 58.2% |
| 15 | aMe3 (R) | Glu | 36 | 18.0 | 1.5% | 59.7% |
| 16 | aMe5 (R) | ACh | 36 | 18.0 | 1.5% | 61.1% |
| 17 | MeVPMe13 (R) | ACh | 36 | 18.0 | 1.5% | 62.6% |
| 18 | Dm8a (R) | Glu | 35 | 17.5 | 1.4% | 64.1% |
| 19 | aMe2 (R) | Glu | 34 | 17.0 | 1.4% | 65.5% |
| 20 | l-LNv (R) | unclear | 34 | 17.0 | 1.4% | 66.9% |
| 21 | aMe23 (R) | unclear | 33 | 16.5 | 1.4% | 68.2% |
| 22 | MeVP9 (R) | ACh | 30 | 15.0 | 1.2% | 69.5% |
| 23 | aMe1 (R) | GABA | 28 | 14.0 | 1.2% | 70.6% |
| 24 | MeVC21 (R) | Glu | 27 | 13.5 | 1.1% | 71.7% |
| 25 | MeVPaMe2 (R) | Glu | 26 | 13.0 | 1.1% | 72.8% |
| 26 | MeVC20 (R) | Glu | 24 | 12.0 | 1.0% | 73.8% |
| 27 | Dm8b (R) | Glu | 23 | 11.5 | 0.9% | 74.7% |
| 28 | MeVP14 (R) | ACh | 23 | 11.5 | 0.9% | 75.7% |
| 29 | aMe10 (R) | ACh | 22 | 11.0 | 0.9% | 76.6% |
| 30 | Mi15 (R) | ACh | 21 | 10.5 | 0.9% | 77.4% |
| 31 | MeVPMe3 (R) | Glu | 20 | 10.0 | 0.8% | 78.3% |
| 32 | PLP231 (R) | unclear | 20 | 10.0 | 0.8% | 79.1% |
| 33 | SLP250 (R) | unclear | 19 | 9.5 | 0.8% | 79.9% |
| 34 | Cm11d (R) | ACh | 18 | 9.0 | 0.7% | 80.6% |
| 35 | Cm8 (R) | GABA | 17 | 8.5 | 0.7% | 81.3% |
| 36 | KCg-s1 (R) | unclear | 17 | 8.5 | 0.7% | 82.0% |
| 37 | MeVPMe12 (L) | ACh | 17 | 8.5 | 0.7% | 82.7% |
| 38 | Lawf1 (R) | ACh | 16 | 8.0 | 0.7% | 83.4% |
| 39 | MeVPMe7 (R) | Glu | 16 | 8.0 | 0.7% | 84.0% |
| 40 | SLP249 (R) | unclear | 16 | 8.0 | 0.7% | 84.7% |
| 41 | aMe12 (R) | ACh | 15 | 7.5 | 0.6% | 85.3% |
| 42 | aMe_TBD1 (R) | unclear | 15 | 7.5 | 0.6% | 85.9% |
| 43 | Cm31b (R) | GABA | 15 | 7.5 | 0.6% | 86.5% |
| 44 | aMe26 (R) | ACh | 13 | 6.5 | 0.5% | 87.1% |
| 45 | MeVP8 (R) | ACh | 12 | 6.0 | 0.5% | 87.6% |
| 46 | Mi19 (R) | 5HT | 12 | 6.0 | 0.5% | 88.1% |
| 47 | Mi17 (R) | GABA | 11 | 5.5 | 0.5% | 88.5% |
| 48 | aMe25 (R) | unclear | 10 | 5.0 | 0.4% | 88.9% |
| 49 | Cm23 (R) | Glu | 10 | 5.0 | 0.4% | 89.3% |
| 50 | MeVP48 (R) | unclear | 10 | 5.0 | 0.4% | 89.7% |
| 51 | Cm26 (R) | Glu | 8 | 4.0 | 0.3% | 90.1% |
| 52 | Dm11 (R) | Glu | 8 | 4.0 | 0.3% | 90.4% |
| 53 | Cm11c (R) | ACh | 7 | 3.5 | 0.3% | 90.7% |
| 54 | Cm21 (R) | GABA | 7 | 3.5 | 0.3% | 91.0% |
| 55 | Lat1 (R) | unclear | 7 | 3.5 | 0.3% | 91.3% |
| 56 | KCg-d (R) | unclear | 6 | 3.0 | 0.2% | 91.5% |
| 57 | MeVPMe11 (R) | Glu | 6 | 3.0 | 0.2% | 91.8% |
| 58 | aMe13 (R) | unclear | 5 | 2.5 | 0.2% | 92.0% |
| 59 | aMe6a (R) | ACh | 5 | 2.5 | 0.2% | 92.2% |
| 60 | Cm11a (R) | ACh | 5 | 2.5 | 0.2% | 92.4% |
| 61 | MeLo1 (R) | ACh | 5 | 2.5 | 0.2% | 92.6% |
| 62 | MeTu3b (R) | ACh | 5 | 2.5 | 0.2% | 92.8% |
| 63 | MeTu3c (R) | ACh | 5 | 2.5 | 0.2% | 93.0% |
| 64 | OA-AL2i4 (R) | OA | 5 | 2.5 | 0.2% | 93.2% |
| 65 | Cm12 (R) | GABA | 4 | 2.0 | 0.2% | 93.4% |
| 66 | Dm2 (R) | ACh | 4 | 2.0 | 0.2% | 93.5% |
| 67 | DN1a (R) | unclear | 4 | 2.0 | 0.2% | 93.7% |
| 68 | MeTu1 (R) | ACh | 4 | 2.0 | 0.2% | 93.9% |
| 69 | MeVP25 (R) | unclear | 4 | 2.0 | 0.2% | 94.0% |
| 70 | MeVP63 (R) | GABA | 4 | 2.0 | 0.2% | 94.2% |
| 71 | SMP217 (R) | unclear | 4 | 2.0 | 0.2% | 94.4% |
| 72 | Cm1 (R) | ACh | 3 | 1.5 | 0.1% | 94.5% |
| 73 | Cm28 (R) | unclear | 3 | 1.5 | 0.1% | 94.6% |
| 74 | Cm29 (R) | GABA | 3 | 1.5 | 0.1% | 94.7% |
| 75 | L1 (R) | Glu | 3 | 1.5 | 0.1% | 94.9% |
| 76 | MeVC22 (R) | Glu | 3 | 1.5 | 0.1% | 95.0% |
| 77 | MeVP2 (R) | ACh | 3 | 1.5 | 0.1% | 95.1% |
| 78 | MeVPMe4 (R) | Glu | 3 | 1.5 | 0.1% | 95.2% |
| 79 | Tm5a (R) | ACh | 3 | 1.5 | 0.1% | 95.3% |
| 80 | aMe12 (L) | ACh | 2 | 1.0 | 0.1% | 95.4% |
| 81 | aMe15 (R) | unclear | 2 | 1.0 | 0.1% | 95.5% |
| 82 | aMe17c (R) | Glu | 2 | 1.0 | 0.1% | 95.6% |
| 83 | CL125 (R) | unclear | 2 | 1.0 | 0.1% | 95.7% |
| 84 | Cm-DRA (R) | ACh | 2 | 1.0 | 0.1% | 95.8% |
| 85 | Cm19 (R) | GABA | 2 | 1.0 | 0.1% | 95.8% |
| 86 | Cm3 (R) | GABA | 2 | 1.0 | 0.1% | 95.9% |
| 87 | Cm35 (R) | GABA | 2 | 1.0 | 0.1% | 96.0% |
| 88 | Cm7 (R) | Glu | 2 | 1.0 | 0.1% | 96.1% |
| 89 | Cm9 (R) | Glu | 2 | 1.0 | 0.1% | 96.2% |
| 90 | Dm10 (R) | GABA | 2 | 1.0 | 0.1% | 96.3% |
| 91 | Dm9 (R) | Glu | 2 | 1.0 | 0.1% | 96.3% |
| 92 | Lat2 (R) | unclear | 2 | 1.0 | 0.1% | 96.4% |
| 93 | MeVP1 (R) | ACh | 2 | 1.0 | 0.1% | 96.5% |
| 94 | MeVP12 (R) | ACh | 2 | 1.0 | 0.1% | 96.6% |
| 95 | MeVP15 (R) | ACh | 2 | 1.0 | 0.1% | 96.7% |
| 96 | MeVP31 (R) | ACh | 2 | 1.0 | 0.1% | 96.7% |
| 97 | MeVP35 (R) | unclear | 2 | 1.0 | 0.1% | 96.8% |
| 98 | MeVP47 (R) | unclear | 2 | 1.0 | 0.1% | 96.9% |
| 99 | MeVP57 (R) | unclear | 2 | 1.0 | 0.1% | 97.0% |
| 100 | MeVPLo2 (R) | ACh | 2 | 1.0 | 0.1% | 97.1% |
| 101 | MeVPLp1 (R) | ACh | 2 | 1.0 | 0.1% | 97.2% |
| 102 | Mi10 (R) | ACh | 2 | 1.0 | 0.1% | 97.2% |
| 103 | Mi16 (R) | GABA | 2 | 1.0 | 0.1% | 97.3% |
| 104 | s-LNv (R) | unclear | 2 | 1.0 | 0.1% | 97.4% |
| 105 | Tm36 (R) | ACh | 2 | 1.0 | 0.1% | 97.5% |
| 106 | Tm38 (R) | ACh | 2 | 1.0 | 0.1% | 97.6% |
| 107 | Tm5b (R) | ACh | 2 | 1.0 | 0.1% | 97.7% |
| 108 | Tm5c (R) | Glu | 2 | 1.0 | 0.1% | 97.7% |